2027 BSF Grant Program supports young and established investigators with seed funding for Barth syndrome research to advance understanding or treatment and generate data for follow-on funding.
Funder: Barth Syndrome Foundation
Due Dates (Anticipated): October 2027 (Full application)
Funding Amounts: Up to US $100,000 total over 1–3 years, plus up to $25,000 for eligible research-participant travel
Summary: Seed funding for innovative Barth syndrome research that advances understanding or treatment and generates data for follow-on funding.
Key Information: Applicants must be independent investigators; predoctoral and postdoctoral fellows cannot apply.
The Barth Syndrome Foundation (BSF) and its International Affiliates support innovative basic, translational, and clinical research addressing Barth syndrome. The program provides seed funding to young and established independent investigators, including work in basic research, discovery science, and early clinical studies. Its goal is to generate preliminary data that can support subsequent funding from major grant-making institutions such as the National Institutes of Health.
Research is assessed for its potential contribution to understanding or treating Barth syndrome, its feasibility, and its prospects for longer-term funding. Preliminary data are not required but are strongly encouraged. Applications that do not align with BSF’s mission, vision, and strategic plan may be administratively dismissed.